相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer
M. Teresa Agullo-Ortuno et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
Josep Tabernero et al.
TARGETED ONCOLOGY (2015)
Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer
T. N. Tran et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Management of non-small-cell lung cancer: recent developments
Martin Reck et al.
LANCET (2013)
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
Giorgio V. Scagliotti et al.
CANCER TREATMENT REVIEWS (2012)
Nedaplatin/gemcitabine versus carboplatin/gemcitabine in treatment of advanced non-small cell lung cancer: A randomized clinical trial
Jin-ji Yang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2012)
Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials
Joseph Treat et al.
LUNG CANCER (2012)
Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma
Simon Ekman et al.
ACTA ONCOLOGICA (2011)
How do anti-mitotic drugs kill cancer cells?
Karen E. Gascoigne et al.
JOURNAL OF CELL SCIENCE (2009)
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
Elizabeth A. Johnson et al.
LUNG CANCER (2008)
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer:: The Swedish Lung Cancer Study Group
C Sederholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
分享论文
